Age (at diagnosis) | 54.23 years | ANA positivity | 12 (40%) |
Sex (female: male) | 2.3:1 | DM-specific antibodies (n = 17) | 12 (70.5%) |
Proximal muscle weakness | 29 (96.7%) | Anti-Jo1 positivity (n = 28) | 0 |
Ro52 (n = 27) | 10 (37.0%) | ||
Raynaud | 2 (6.7%) | Elevated CK (n = 24) | 16 (66.7%) |
Dysphagia | 6 (20.0%) | ||
Arthralgia/arthritis | 11 (36.7%) | Cutaneous involvement | |
ILD | 5 (16.7%) | Heliotrope rash | 27 (90.0%) |
Cancer | 8 (26.7%) | Gottron’s papules | 6 (20.0%) |
Gottron’s sign | 0 | ||
Clinical diagnosis | |||
Definite DM | 14 (46.7%) | Muscle biopsy (n = 24) | |
Probable DM | 12 (40.0%) | Endomysial inflammation | 13 (54.2%) |
Amyopathic DM | 1 (3.3%) | Perimysial/perivascular infl | 7 (29.2%) |
DM sine dermatitis | 3 (10.0%) | Perifascicular atrophy | 16 (66.7%) |
Rimmed vacuoles | 1 (4.1%) | ||
Criteria probability | |||
High | 16 (53.3%) | ||
Medium | 13 (43.3%) | ||
Low | 1 (3.3%) |